ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGY Allergy Therapeutics Plc

3.15
0.00 (0.00%)
13 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.15 3.00 3.30 3.15 3.10 3.15 1,359,810 08:00:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.50 150.14M

Allergy Therapeutics PLC Director/PCA Dealing (1305T)

10/11/2023 1:22pm

UK Regulatory


TIDMAGY

RNS Number : 1305T

Allergy Therapeutics PLC

10 November 2023

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      SkyGem Acquisition Limited 
     ------------------------  ------------------------------------------- 
 2    Reason for the notification 
     --------------------------------------------------------------------- 
 a)   Position / status         Person Closely Associated with Mr. Zheqing 
                                 (Simon) Shen, Non-Executive Director of 
                                 Allergy Therapeutics Plc 
     ------------------------  ------------------------------------------- 
 b)   Initial notification      Initial notification 
       / amendment 
     ------------------------  ------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     --------------------------------------------------------------------- 
 a)   Name                      Allergy Therapeutics plc 
     ------------------------  ------------------------------------------- 
 b)   LEI                       213800PQ7AHK7KGVOE23 
     ------------------------  ------------------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     --------------------------------------------------------------------- 
 a)   Description of            Ordinary shares of GBP0.001 each 
       the financial             ISIN: GB00B02LCQ05 
       instrument, type 
       of instrument 
       Identification 
       code 
     ------------------------  ------------------------------------------- 
 b)   Nature of the             Acquisition of Ordinary Shares pursuant 
       transaction               to the mandatory offer 
     ------------------------  ------------------------------------------- 
 c)   Price(s) and 
       volume(s)                   Price(s)    Volume(s) 
                                   GBP0.01     247,935,057 
                                              ------------ 
     ------------------------  ------------------------------------------- 
 d)   Aggregated information 
       - Aggregated               n/a 
       volume 
       - Price 
     ------------------------  ------------------------------------------- 
 e)   Date of the transaction   9 November 2023 
     ------------------------  ------------------------------------------- 
 f)   Place of the              Outside a trading venue 
       transaction 
     ------------------------  ------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBMBJTMTBBBLJ

(END) Dow Jones Newswires

November 10, 2023 08:22 ET (13:22 GMT)

1 Year Allergy Therapeutics Chart

1 Year Allergy Therapeutics Chart

1 Month Allergy Therapeutics Chart

1 Month Allergy Therapeutics Chart

Your Recent History

Delayed Upgrade Clock